ANG II is required for optimal overload-induced skeletal muscle hypertrophy.

ANG II mediates the hypertrophic response of overloaded cardiac muscle, likely via the ANG II type 1 (AT(1)) receptor. To examine the potential role of ANG II in overload-induced skeletal muscle hypertrophy, plantaris and/or soleus muscle overload was produced in female Sprague-Dawley rats (225-250 g) by the bilateral surgical ablation of either the synergistic gastrocnemius muscle (experiment 1) or both the gastrocnemius and plantaris muscles (experiment 2). In experiment 1 (n = 10/group), inhibiting endogenous ANG II production by oral administration of an angiotensin-converting enzyme (ACE) inhibitor during a 28-day overloading protocol attenuated plantaris and soleus muscle hypertrophy by 57 and 96%, respectively (as measured by total muscle protein content). ACE inhibition had no effect on nonoverloaded (sham-operated) muscles. With the use of new animals (experiment 2; n = 8/group), locally perfusing overloaded soleus muscles with exogenous ANG II (via osmotic pump) rescued the lost hypertrophic response in ACE-inhibited animals by 71%. Furthermore, orally administering an AT(1) receptor antagonist instead of an ACE inhibitor produced a 48% attenuation of overload-induced hypertrophy that could not be rescued by ANG II perfusion. Thus ANG II may be necessary for optimal overload-induced skeletal muscle hypertrophy, acting at least in part via an AT(1) receptor-dependent pathway.

[1]  H. E. Montgomery,et al.  Physiology: The ACE gene and muscle performance , 2000, Nature.

[2]  Daniel E. Koshland,et al.  Structural biology: A new model for protein stereospecificity , 2000, Nature.

[3]  Nancy Gibbs,et al.  Life and Death , 2000, Nature.

[4]  V. Petrov,et al.  Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. , 1999, Journal of molecular and cellular cardiology.

[5]  F. Booth,et al.  Effect of serum and mechanical stretch on skeletal α-actin gene regulation in cultured primary muscle cells. , 1998, American journal of physiology. Cell physiology.

[6]  M. Volterrani,et al.  Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition. , 1998, Circulation.

[7]  A. Greene.  Life and Death in the Microcirculation: a Role for Angiotensin II , 1998, Microcirculation.

[8]  Jimmy D Bell,et al.  Human gene for physical performance , 1998, Nature.

[9]  P. Buttery,et al.  Nutritional and hormonal control of skeletal-muscle cell growth and differentiation , 1998, Proceedings of the Nutrition Society.

[10]  B. Olmstead,et al.  Time course of changes in capillarization in hypertrophied rat plantaris muscle. , 1998, Journal of applied physiology.

[11]  T. Ogihara,et al.  Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans. , 1997, Circulation.

[12]  E. Olson,et al.  Angiotensin II-induced stimulation of smooth muscle alpha-actin expression by serum response factor and the homeodomain transcription factor MHox. , 1997, Circulation research.

[13]  M. Yano,et al.  Dose-dependent effect of ANG II-receptor antagonist on myocyte remodeling in rat cardiac hypertrophy. , 1997, American journal of physiology. Heart and circulatory physiology.

[14]  A. Danser,et al.  Angiotensin II type 1 (AT1) receptor-mediated accumulation of angiotensin II in tissues and its intracellular half-life in vivo. , 1997, Hypertension.

[15]  A. Muscella,et al.  AT1 angiotensin II receptor subtype in the human larynx and squamous laryngeal carcinoma. , 1996, Cancer letters.

[16]  K. Swedberg,et al.  Skeletal muscle changes in patients with chronic heart failure before and after treatment with enalapril. , 1996, European heart journal.

[17]  E. Núñez,et al.  Angiotensin II increases left ventricular mass without affecting myosin isoform mRNAs. , 1996, Hypertension.

[18]  R E Grindeland,et al.  IGF-I, growth hormone, and/or exercise effects on non-weight-bearing soleus of hypophysectomized rats. , 1996, Journal of applied physiology.

[19]  R. Schwartz,et al.  SRF and TEF-1 control of chicken skeletal alpha-actin gene during slow-muscle hypertrophy. , 1996, The American journal of physiology.

[20]  W J Kraemer,et al.  Strength and Power Training: Physiological Mechanisms of Adaptation , 1996, Exercise and sport sciences reviews.

[21]  E. Sonnenblick,et al.  Identification and activation of autocrine renin-angiotensin system in adult ventricular myocytes. , 1995, The American journal of physiology.

[22]  D E Ingber,et al.  Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. , 1995, Molecular biology of the cell.

[23]  H. Vandenburgh,et al.  Collagen and Stretch Modulate Autocrine Secretion of Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Proteins from Differentiated Skeletal Muscle Cells (*) , 1995, The Journal of Biological Chemistry.

[24]  K. Irie,et al.  Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery , 1994, British journal of pharmacology.

[25]  P. Hjemdahl,et al.  Angiotensin II overflow from canine skeletal muscle in vivo: importance of plasma angiotensin I. , 1994, The American journal of physiology.

[26]  K. Weber,et al.  Angiotensin-converting enzyme, bradykinin, and angiotensin II receptor binding in rat skin, tendon, and heart valves: an in vitro, quantitative autoradiographic study. , 1994, The Journal of laboratory and clinical medicine.

[27]  J. Sadoshima,et al.  Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro , 1993, Cell.

[28]  M. Phillips,et al.  Levels of angiotensin and molecular biology of the tissue renin angiotensin systems , 1993, Regulatory Peptides.

[29]  A. Danser,et al.  Production of angiotensins I and II at tissue sites in intact pigs. , 1992, The American journal of physiology.

[30]  K. Baker,et al.  Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart. Mediation by the AT1 receptor. , 1992, American journal of hypertension.

[31]  H. Vandenburgh.  Mechanical forces and their second messengers in stimulating cell growth in vitro. , 1992, The American journal of physiology.

[32]  K. Baker,et al.  Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. , 1990, The American journal of physiology.

[33]  M. I. Steinberg,et al.  Binding and pharmacologic properties of peptides derived from human and rat angiotensin II (AII) mRNA. , 1990, Biochemical and biophysical research communications.

[34]  R. Prewitt,et al.  Captopril Reduces Aortic and Microvascular Growth in Hypertensive and Normotensive Rats , 1990, Hypertension.

[35]  B. Berk,et al.  Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. , 1989, Hypertension.

[36]  H. Drexler,et al.  Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial. , 1989, Circulation.

[37]  M. Peach,et al.  Angiotensin II Induces Hypertrophy, not Hyperplasia, of Cultured Rat Aortic Smooth Muscle Cells , 1988, Circulation research.

[38]  P. Poole‐Wilson,et al.  Abnormalities of skeletal muscle in patients with chronic heart failure. , 1988, International journal of cardiology.

[39]  Robert S. Pinals,et al.  A double‐blind, placebo‐controlled trial , 1986 .

[40]  T. Lømo,et al.  Firing patterns of motor units in normal rats , 1985, Nature.

[41]  H. Vandenburgh.  Cell shape and growth regulation in skeletal muscle: Exogenous versus endogenous factors , 1983, Journal of cellular physiology.

[42]  R. Roy,et al.  Biochemical properties of overloaded fast-twitch skeletal muscle. , 1982, Journal of applied physiology: respiratory, environmental and exercise physiology.

[43]  C. Ianuzzo,et al.  Metabolic character of hypertrophied rat muscle. , 1979, Journal of applied physiology: respiratory, environmental and exercise physiology.

[44]  R. Pratt,et al.  Angiotensin II and the control of cardiovascular structure. , 1999, Journal of the American Society of Nephrology : JASN.

[45]  T. Ogihara,et al.  [Upregulation of angiotensin-converting enzyme during the healing process after injury at the site of percutaneous transluminal coronary angioplasty in humans]. , 1998, Journal of cardiology.

[46]  K. Burridge,et al.  Focal adhesions, contractility, and signaling. , 1996, Annual review of cell and developmental biology.